Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mingshui Fukang Chemical is a Chinese fine chemical and pharmaceutical intermediate manufacturer founded in 2004 and based in Mingshui County, Suihua, Heilongjiang. The company produces chiral amines and fosfomycin-related intermediates, including D- and L-phenylethylamine and L-cis-1,2-epoxypropylphosphonic acid-D-\u03b1-phenylethylamine, which are used in pharmaceutical chemical manufacturing. Public supplier profiles describe it as a supporting enterprise for Harbin Pharmaceutical Group affiliates, particularly in the fosfomycin sodium supply chain. The business appears to be focused on commercial-scale manufacturing rather than innovative drug development, with production workshops and export capability for specialty chemical products. It is best characterized as a small-molecule pharmaceutical intermediate company rather than a biotech therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mingshui Fukang Chemical.